Common Contracts
8 similar Employment Agreement contracts by Assembly Biosciences, Inc., Ventrus Biosciences Inc
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • February 28th, 2019 • Assembly Biosciences, Inc. • Pharmaceutical preparations • California
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”), is entered into on October 10, 2018 (the “Effective Date“), by and between Assembly Biosciences, Inc., a Delaware corporation with principal executive offices at 11711 N. Meridian Street, Suite 310, Carmel, IN 46032 (the “Company”), and Jackie Papkoff, Ph.D. (the “Executive”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • October 12th, 2018 • Assembly Biosciences, Inc. • Pharmaceutical preparations • California
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”), is entered into on October 10, 2018 (the “Effective Date“), by and between Assembly Biosciences, Inc., a Delaware corporation with principal executive offices at 11711 N. Meridian Street, Suite 310, Carmel, IN 46032 (the “Company”), and Uri A. Lopatin, MD (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • May 7th, 2018 • Assembly Biosciences, Inc. • Pharmaceutical preparations • California
This EMPLOYMENT AGREEMENT (the “Agreement”), is entered into on March 8, 2018 (the “Effective Date”), by and between Assembly Biosciences, Inc., a Delaware corporation with principal executive offices at 11711 N. Meridian Street, Suite 310, Carmel, IN 46032 (the “Company”), and Graham Cooper (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • March 2nd, 2017 • Assembly Biosciences, Inc. • Pharmaceutical preparations • California
This EMPLOYMENT AGREEMENT (the “Agreement”), is entered into as of September 14, 2016, with an effective date of September 26, 2016 (the “Effective Date”), by and between Assembly Biosciences, Inc., a Delaware corporation with principal executive offices at 11711 N. Meridian Street, Suite 310, Carmel, IN 46032 (the “Company”), and Miguel S. Barbosa, Ph.D. (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • November 9th, 2016 • Assembly Biosciences, Inc. • Pharmaceutical preparations • California
This EMPLOYMENT AGREEMENT (the “Agreement”), is entered into as of December 17th, 2015, with an effective date of January 5th, 2016 (the “Effective Date”), by and between Assembly BioSciences, Inc., a Delaware corporation with principal executive offices at 99 Hudson Street, 5th Floor, New York, NY 10013 (the “Company”), and Richard Colonno, Ph.D, residing at ## ######## #####, #######, ## ##### (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • July 14th, 2014 • Assembly Biosciences, Inc. • Pharmaceutical preparations • New York
This EMPLOYMENT AGREEMENT (the “Agreement”), is entered into as of July 10, 2014, with an effective date of July 11, 2014 (the “Effective Date”), by and between Ventrus Biosciences, Inc., a Delaware corporation with principal executive offices at 99 Hudson Street, 5th Floor, New York, NY 10013 (the “Company”), and Derek Small, residing at 4392 Creekside Pass, Zionsville, IN 46077 (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • January 16th, 2014 • Ventrus Biosciences Inc • Pharmaceutical preparations • New York
This EMPLOYMENT AGREEMENT (the “Agreement”), is entered into as of January 15, 2014, with an effective date of December 22, 2013 (the “Effective Date”), by and between Ventrus BioSciences, Inc., a Delaware corporation with principal executive offices at 99 Hudson Street, New York, NY 10013 (the “Company”), and Russell H. Ellison, MD, residing at 245 West 84th, Apt. 9E, New York, NY 10024 (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • January 16th, 2014 • Ventrus Biosciences Inc • Pharmaceutical preparations • New York
This EMPLOYMENT AGREEMENT (the “Agreement”), is entered into as of January 15, 2014, with an effective date of December 22, 2013 (the “Effective Date”), by and between Ventrus BioSciences, Inc., a Delaware corporation with principal executive offices at 99 Hudson Street, New York, NY 10013 (the “Company”), and David Barrett, residing at 34 Desbrossess Street, NY, NY 10013 (the “Executive”).
